Atomoxetine in the treatment of the most common comorbid disorders of attention-deficit / hyperactivity disorder, oppositional defiant disorder and anxiety disorders / Snircova E. ... [et al.]. Acta medica Martiniana Roč. 12, č. 3 (2012), s. 28-38